Vanguard PRIMECAP Inv (VPMCX)
136.99
-0.90 (-0.65%)
USD |
Feb 03 2023
Returns Chart
Key Stats
Customize
| Expense Ratio | Total Assets Under Management | Dividend Yield | Turnover Ratio |
|---|---|---|---|
| 0.38% | 59.85B | 1.13% | 3.00% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized All Time Total Returns (Daily) | Max Drawdown (All) |
| -4.561B | -2.78% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The investment seeks long-term capital appreciation. The fund invests in stocks considered to have above-average earnings growth potential that is not reflected in their current market prices. Its portfolio consists predominantly of large- and mid-capitalization stocks. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | VPMCX |
| Equity Style | Large Cap/Blend |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Large Blend |
| Category Index | Russell 1000 TR USD |
| Global Category Name | US Equity Large Cap Blend |
| YCharts Categorization | US Large Cap Blend |
| YCharts Benchmark | S&P 500 Total Return (^SPXTR) |
| Prospectus Objective | Growth |
| Fund Owner Firm Name | Vanguard |
| Prospectus Benchmark Index | |
| S&P 500 TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| Theo Kolokotrones | 37.61 yrs |
| Joel Fried | 34.02 yrs |
| Alfred Mordecai | 23.02 yrs |
| M. Ansari | 15.01 yrs |
| James Marchetti | 7.93 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
98
-4.561B
-24.39B
Category Low
47.81B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of December 31, 2022
Performance Versus Category
As of February 03, 2023. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of February 03, 2023.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Eli Lilly and Co | 9.45% | 339.08 | 2.53% |
| Biogen Inc | 4.20% | 283.63 | -1.35% |
| Amgen Inc | 4.12% | 245.17 | -0.55% |
| Microsoft Corp | 3.38% | 258.35 | -2.36% |
| Texas Instruments Inc | 3.06% | 182.29 | -1.32% |
| AstraZeneca PLC ADR | 2.53% | 63.44 | 0.46% |
| FedEx Corp | 2.40% | 214.67 | 0.08% |
| Adobe Inc | 2.38% | 379.33 | -3.29% |
| Tesla Inc | 2.38% | 189.98 | 0.91% |
| Wells Fargo & Co | 2.27% | 47.58 | 0.74% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | -- |
| Actual Management Fee | Upgrade |
| Administration Fee | -- |
| Performance Fee | -- |
| Switching Fee | -- |
| Transaction Fee | -- |
| Maximum Front Load | -- |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | -- |
Basic Info
| Investment Strategy | |
| The investment seeks long-term capital appreciation. The fund invests in stocks considered to have above-average earnings growth potential that is not reflected in their current market prices. Its portfolio consists predominantly of large- and mid-capitalization stocks. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | VPMCX |
| Equity Style | Large Cap/Blend |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Large Blend |
| Category Index | Russell 1000 TR USD |
| Global Category Name | US Equity Large Cap Blend |
| YCharts Categorization | US Large Cap Blend |
| YCharts Benchmark | S&P 500 Total Return (^SPXTR) |
| Prospectus Objective | Growth |
| Fund Owner Firm Name | Vanguard |
| Prospectus Benchmark Index | |
| S&P 500 TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| Theo Kolokotrones | 37.61 yrs |
| Joel Fried | 34.02 yrs |
| Alfred Mordecai | 23.02 yrs |
| M. Ansari | 15.01 yrs |
| James Marchetti | 7.93 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (2-3-23) | 1.13% |
| 30-Day SEC Yield (1-27-23) | Upgrade |
| 7-Day SEC Yield (11-28-03) | Upgrade |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | 18.49 |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of October 31, 2022
Growth Estimates
Fund Details
| Key Dates | |
| Inception Date | 11/1/1984 |
| Last Annual Report Date | 9/30/2022 |
| Last Prospectus Date | 1/31/2022 |
| Share Classes | |
| VPMAX | Inst |
| Attributes | |
| Index Fund | No |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |